Preparation of silibinin- dendrimer-stabilized Au nanoparticles for decreasing vancomycin resistance in S. aureus clinical isolates
- 7 January 2026
- journal article
- research article
- Published by Springer Nature in International Microbiology
- Vol. 29 (2) , 197-213
Abstract
Introduction Silibinin (SB), a bioactive flavonolignan derived from milk thistle seeds (Silybum marianum L.), exhibits well-documented antioxidant, antibacterial, antifungal, antiviral, and hepatoprotective activities. This study aimed to conjugate SB with fourth-generation poly(amidoamine) dendrimer-stabilized gold nanoparticles (DSA) to enhance its solubility and evaluate its antibacterial efficacy against clinical isolates of Staphylococcus aureus (S. aureus). Methods The morphology and structural features of silibinin-dendrimer-stabilized gold nanoparticle complex (SB-DSA) were characterized using Fourier-transform infrared spectroscopy (FTIR), dynamic light scattering (DLS), transmission electron microscopy (TEM) and field-emission scanning electron microscopy (FE-SEM). Antibacterial activity was assessed through biofilm formation assays, checkerboard analysis, and quantitative real-time PCR (qRT-PCR) using clinical S. aureus isolates and a standard reference strain. Results Physicochemical analyses confirmed the successful incorporation of SB into the DSA matrix. The average particle size of the SB-DSA nanocomposites was approximately 20 nm. A synergistic interaction between SB-DSA and vancomycin was observed, with SB-DSA significantly enhancing the susceptibility of vancomycin-resistant isolates to vancomycin. Biofilm formation was markedly reduced in resistant isolates treated with the SB-DSA/vancomycin combination compared with vancomycin alone. The time-kill kinetics of SB-DSA in the tested isolates ranged from 4 to 8 h. Combination treatment also resulted in downregulation of icaA, and norA expression in resistant S. aureus isolates. Conclusion Silibinin encapsulated within DSA demonstrates potent anti S. aureus activity, likely mediated through downregulation of efflux pump-related genes and improved intracellular retention of vancomycin. Consequently, even low concentrations of vancomycin, when combined with silibinin, effectively inhibited the growth of vancomycin-resistant isolates. Graphical abstractKeywords
This publication has 66 references indexed in Scilit:
- Silibinin encapsulation in polymersome: A promising anticancer nanoparticle for inducing apoptosis and decreasing the expression level of miR‐125b/miR‐182 in human breast cancer cellsJournal of Cellular Physiology, 2019
- Synthesis and characterization of fourth generation polyester‐based dendrimers with cationic amino acids‐modified crown as promising water soluble biomedical devicesPolymers for Advanced Technologies, 2018
- Functional dendrimer–gold nanoparticle hybrids for biomedical applicationsPolymer International, 2018
- Polyamido amine (PAMAM)-grafted magnetic nanotubes as emerging platforms for the delivery and sustained release of silibininJournal of Materials Science, 2017
- Reduction of Metal Ions in Polymer Matrices as a Condensation Method of Nanocomposite Synthesis2014
- Targeted Delivery of Pesticides Using Biodegradable Polymeric Nanoparticles2014
- Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infectionHepatology, 2012
- Synergistic effects between silibinin and antibiotics on methicillin‐resistant Staphylococcus aureus isolated from clinical specimensBiotechnology Journal, 2011
- Multiple Effects of Silymarin on the Hepatitis C Virus LifecycleHepatology, 2010
- Synthesis and characterization of gold nanocomposites with modified and intact polyamidoamine dendrimersMicrochimica Acta, 2009